Compare Aehr Test Systems (AEHR) vs JPMorgan Chase & Co (JPM) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
Aehr Test Systems vs JPMorgan Chase & Co — how do they compare? Aehr Test Systems trades at $65.81 (market cap $2.11B), while JPMorgan Chase & Co trades at $333.74 (market cap $908.94B). The key difference: JPMorgan Chase & Co is far larger — about 430.8× Aehr Test Systems's market cap, and JPMorgan Chase & Co pays a 1.77% dividend while Aehr Test Systems pays none. Which is the better fit depends on your goals.
| AEHR | JPM | |
|---|---|---|
Market Cap | $2.11B | $908.94B |
Sector | Technology | Financials |
52-Week High | $116.58 | $339.22 |
52-Week Low | $13.29 | $282.78 |
Enterprise Value | $2.08B | — |
Volume | — | 10,479,943 |
Dividend Yield | — | 1.77% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
AEHR trades at $72.33, up 3.38% today, with a bullish technical signal driven by oversold RSI readings near 24.5, though moving averages remain bearish. The company reported Q1 2026 EPS of -$0.05, beating expectations, but maintains negative profitability margins and cash flow. Recent news highlights strong order growth from AI and silicon photonics customers, including a follow-on system order announced June 17, 2026.
Outlook is mixed: robust order book and AI sector tailwinds support growth, but high P/S of 46.6 and persistent losses pose valuation risks. Analyst consensus is cautious with 33% buy ratings. Key risks include execution on orders and cash burn.
JPMorgan Chase (JPM) trades at $332.64, down 1.5% on the day, as investors await Q2 2026 earnings results. The stock maintains a bullish technical outlook with strong moving average support and shows solid fundamentals with $181.85B revenue and 31.61% net income margin for 2025. Recent earnings beats in Q1 2026 ($5.94 vs $5.47 expected) demonstrate operational strength, while analyst consensus remains positive with a $360.38 price target.
JPMorgan presents a compelling investment case with industry-leading 17.03% ROE and reasonable 16.24 P/E valuation. Near-term catalysts include upcoming earnings and dividend payment, though risks persist from geopolitical tensions, cybersecurity threats, and CEO Dimon's warnings about economic challenges. The stock offers stability with institutional support but faces headwinds from interest rate sensitivity and global economic uncertainty.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Aehr Test Systems
Aehr Test Systems provides testing and burn-in solutions for the semiconductor industry. Its systems ensure the reliability of AI processors, data center chips, and electric vehicle components at the wafer and package levels.
Read more on AEHR →About JPMorgan Chase & Co
JPMorgan Chase & Co. provides global financial services and retail banking. The Company provides services such as investment banking, treasury and securities services, asset management, private banking, card member services, commercial banking, and home finance. JP Morgan Chase serves business enterprises, institutions, and individuals.
Read more on JPM →
